Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
Clinical trial NCT00553618 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00553618
- Sponsor
- University of Louisville
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2025-08-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.